{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-096810","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2026-09-02T21:29:10+00:00","discovered_at":"2026-09-02T21:30:03.455259+00:00","generated_at":"2026-09-02T21:30:12.177002+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BioRestorative Therapies announces 1-for-20 reverse stock split to regain Nasdaq compliance","bullets":["1-for-20 reverse split effective 4:30 p.m. ET Sept 7, 2026; trading starts Sept 8, 2026 on Nasdaq under BRTX with new CUSIP 090655705.","Outstanding shares reduced from 27,622,556 to ~1,381,128; authorized shares cut from 1.5B to 75M.","Board approved split without stockholder approval under Nevada law; fractional shares rounded up to whole share.","Split aims to regain compliance with Nasdaq $1.00 minimum bid price rule (Listing Rule 5550(a)(2))."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-096810","json":"https://secwatch.observer/filing/0001213900-26-096810.json","markdown":"https://secwatch.observer/filing/0001213900-26-096810.md","text":"https://secwatch.observer/filing/0001213900-26-096810.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000121390026096810/0001213900-26-096810-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000121390026096810/ea0304389-8k_biore.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T21:30:12.177002+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}